AI assistant
ABBOTT LABORATORIES — Director's Dealing 2014
Apr 2, 2014
29777_dirs_2014-04-02_f012f043-db51-4e08-9138-1206f9c00652.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-03-31
Reporting Person: Contreras Jaime (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-31 | Common shares without par value | A | 979 | — | Acquired | 2046 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 30136 | Direct |
| Common shares without par value | 20 | Indirect |
| Common shares without par value | 16 | Indirect |
| Common shares without par value | 63903 | Indirect |
| Common shares without par value | 12081 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2014.
F2: Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
F3: This grant represents a restricted stock unit award under the Abbott Laboratories 2009 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting on each anniverary of the grant date. The award includes the right to have stock withheld for tax purposes.
F4: Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.